Seven Mile Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Seven Mile Advisory's AMGN Position: Q1 2026 in Review
Seven Mile Advisory reduced its Amgen (AMGN) stake by 29% in Q1 2026, selling an estimated $214K and leaving 1,477 shares worth $520K. The position accounts for 0.38% of the portfolio, ranked #54.
Seven Mile Advisory first reported a position in AMGN in Q3 2023 and has held it in 10 quarters since. The position peaked at $680K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Seven Mile Advisory held 1,477 shares of Amgen worth $520K as of Q1 2026.
- Seven Mile Advisory sold 600 Amgen shares in Q1 2026, an estimated $214K.
- Amgen made up 0.38% of Seven Mile Advisory's portfolio in Q1 2026, its #54 holding.
- Seven Mile Advisory first reported a position in Amgen in Q3 2023 and has held it in 10 quarters since.
- Seven Mile Advisory's Amgen position peaked at $680K in Q4 2025.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Seven Mile Advisory's 13F filing for Q1 2026, filed 14 Apr 2026.